Esra Camci

Esra Camci has a Ph.D. in Biochemistry and Molecular Biology from the University of Washington. Esra has worked as a Scientist II at Prime Medicine, Inc. focusing on Genetic Hearing Loss. Prior to that, Esra was a Scientist I at Oxford Biomedica Solutions, where Esra worked on developing NGS assays for AAV-mediated gene therapies. Esra's research background includes studying aminoglycoside and cisplatin-associated hearing loss as a Postdoctoral Research Fellow at the University of Washington - School of Medicine. During their time as a Graduate Research Assistant at the University of Washington, Esra focused on genetics and developmental biology underlying facial dysmorphology.